Nano Dimension Ltd.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
NNDM$1.32+5.2%Stored close · as of Nov 6, 2026
Contents
Item 1. Condensed Consolidated Balance Sheets as of September 30, 2026 (Unaudited)and December 31, 2025
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data) (Unaudited)
| September 30, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| Assets | ||
| Cash and cash equivalents | $314,852 | $204,672 |
| Bank deposits | — | 168,997 |
| Marketable equity securities | 80,566 | 84,154 |
| Restricted bank deposits | 1,169 | 123 |
| Trade receivables, net of allowance for credit losses ($739 and $861, respectively) | 27,832 | 26,047 |
| Inventory | 29,968 | 32,878 |
| Other current assets | 12,462 | 8,938 |
| Total current assets | 466,849 | 525,809 |
| Restricted bank deposits | 270 | 1,610 |
| Property, plant and equipment, net | 14,174 | 24,840 |
| Operating lease right-of-use assets | 7,915 | 23,789 |
| Deferred tax assets | 424 | 424 |
| Goodwill | — | 40,388 |
| Intangible assets, net | 16,826 | 19,434 |
| Other assets | 1,501 | 1,930 |
| Total assets | $507,959 | $638,224 |
| Liabilities and Equity | ||
| Trade payables | $10,292 | $11,999 |
| Accrued liabilities | 23,381 | 19,514 |
| Deferred revenue | 11,858 | 11,873 |
| Current portion of lease liability | 2,045 | 8,923 |
| Current portion of bank loan | 150 | 158 |
| Current settlement payable - related party | 14,700 | — |
| Total current liabilities | 62,426 | 52,467 |
| Employee benefits | 2,524 | 3,697 |
| Operating lease liabilities | 3,068 | 23,323 |
| Bank loan | 37 | 158 |
| Long-term settlement payable | 3,422 | 2,974 |
| Long-term deferred revenue | 3,562 | 3,617 |
| Total liabilities | 75,039 | 86,236 |
| Commitments and contingencies (Note 12) | ||
| Equity: | ||
| Share capital of NIS 5 par value each; 500,000,000 ordinary shares authorized; 204,003,865 and 206,811,875 shares outstanding as of September 30, 2026 and December 31, 2025, respectively, and 283,521,031 and 279,306,522 shares issued as of September 30, 2026 and December 31, 2025, respectively. | 424,033 | 417,084 |
| Additional paid-in capital | 1,295,932 | 1,297,323 |
| Treasury stock | (203,581) | (192,507) |
| Accumulated other comprehensive income | 2,617 | 1,048 |
| Accumulated loss | (1,086,081) | (970,960) |
| Total equity | 432,920 | 551,988 |
| Total liabilities and equity | $507,959 | $638,224 |
| See Notes to Condensed Consolidated Financial Statements. | ||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In thousands, except share data) (Unaudited)
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenue: | ||||
| Product | $26,230 | $20,199 | $73,142 | $51,942 |
| Service | 5,685 | 6,685 | 17,461 | 15,180 |
| Total revenue | 31,915 | 26,884 | 90,603 | 67,122 |
| Cost of revenue: | ||||
| Product | 14,197 | 15,187 | 41,605 | 38,678 |
| Service | 3,277 | 3,553 | 9,136 | 7,416 |
| Total cost of revenue | 17,474 | 18,740 | 50,741 | 46,094 |
| Gross profit | 14,441 | 8,144 | 39,862 | 21,028 |
| Operating expenses: | ||||
| Research and development | 4,914 | 8,530 | 18,903 | 22,588 |
| Sales and marketing | 7,882 | 10,097 | 25,979 | 25,648 |
| General and administrative | 33,620 | 14,210 | 61,741 | 41,985 |
| Restructuring and other | 5,815 | 2,021 | 15,706 | 7,049 |
| Desktop Metal litigation | — | 693 | — | 32,008 |
| Impairment losses | 1,190 | 5,721 | 41,578 | 8,406 |
| Operating loss | (38,980) | (33,128) | (124,045) | (116,656) |
| Gain (loss) on investment in marketable equity securities | (2,424) | (2,617) | (3,587) | 22,396 |
| Other expense, net | (167) | (150) | (175) | (206) |
| Finance income | 3,137 | 6,674 | 13,550 | 28,697 |
| Finance expense | (245) | (258) | (738) | (521) |
| Loss before income taxes | (38,679) | (29,479) | (114,995) | (66,290) |
| Income tax expense (benefit) | (24) | 24 | 126 | 123 |
| Net loss from continuing operations | (38,655) | (29,503) | (115,121) | (66,413) |
| Net loss from discontinued operations, net of income tax of nil | — | (23,502) | — | (193,263) |
| Net loss | (38,655) | (53,005) | (115,121) | (259,676) |
| Less: Net loss attributable to non-controlling interests | — | — | — | (323) |
| Net loss attributable to common shareholders | $(38,655) | $(53,005) | $(115,121) | $(259,353) |
| Net loss attributable to common shareholders: | ||||
| Continuing operations - basic and diluted | $(0.18) | $(0.13) | $(0.55) | $(0.30) |
| Discontinued operations - basic and diluted | $— | $(0.11) | $— | $(0.89) |
| Weighted average common shares outstanding, basic and diluted | 209,408 | 218,854 | 208,919 | 217,663 |
| Net loss | $(38,655) | $(53,005) | $(115,121) | $(259,676) |
| Other comprehensive income: | ||||
| Foreign currency translation adjustment | 548 | (107) | 915 | 1,571 |
| Remeasurement of pension and post-employment benefit plans, net of tax | — | — | 654 | — |
| Comprehensive loss | (38,107) | (53,112) | (113,552) | (258,105) |
| Less: Comprehensive loss attributable to non-controlling interests | — | — | — | (224) |
| Comprehensive loss attributable to common shareholders | $(38,107) | $(53,112) | $(113,552) | $(257,881) |
| See Notes to Condensed Consolidated Financial Statements. | ||||
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(In thousands) (Unaudited)
| ShareCapital | AdditionalPaid-InCapital | TreasuryStock | AccumulatedOtherComprehensiveIncome (Loss) | AccumulatedDeficit | Total | Non-ControllingInterests | TotalEquity | |
|---|---|---|---|---|---|---|---|---|
| December 31, 2024 | $409,145 | $1,297,348 | $(167,651) | $(1,137) | $(677,665) | $860,040 | $715 | $860,755 |
| Net loss | — | — | — | — | (25,312) | (25,312) | (236) | (25,548) |
| Other comprehensive income for the period | — | — | — | 581 | — | 581 | 12 | 593 |
| Exercise of options and vesting of RSUs | 1,828 | (1,828) | — | — | — | — | — | — |
| Share-based compensation expense | — | (786) | — | — | — | (786) | — | (786) |
| March 31, 2025 | 410,973 | 1,294,734 | (167,651) | (556) | (702,977) | 834,523 | 491 | 835,014 |
| Net loss | — | — | — | — | (181,036) | (181,036) | (87) | (181,123) |
| Other comprehensive income for the period | — | — | — | 1,112 | — | 1,112 | 29 | 1,141 |
| Exercise of options and vesting of RSUs | 1,793 | (1,793) | — | — | — | — | — | — |
| Share-based compensation for pre-combination service | — | 2,054 | — | — | — | 2,054 | — | 2,054 |
| Share-based compensation expense | — | 2,430 | — | — | — | 2,430 | — | 2,430 |
| Deconsolidation of subsidiaries | — | — | — | 26 | — | 26 | (433) | (407) |
| June 30, 2025 | 412,766 | 1,297,425 | (167,651) | 582 | (884,013) | 659,109 | — | 659,109 |
| Net loss | — | — | — | — | (53,005) | (53,005) | — | (53,005) |
| Other comprehensive loss for the period | — | — | — | (107) | — | (107) | — | (107) |
| Exercise of options and vesting of RSUs | 3,105 | (3,105) | — | — | — | — | — | — |
| Repurchase of treasury shares | — | — | (5,613) | — | — | (5,613) | — | (5,613) |
| Share-based compensation expense | — | 1,375 | — | — | — | 1,375 | — | 1,375 |
| Deconsolidation of subsidiaries | — | — | — | — | — | — | — | — |
| September 30, 2025 | $415,871 | $1,295,695 | $(173,264) | $475 | $(937,018) | $601,759 | $— | $601,759 |
| December 31, 2025 | $417,084 | $1,297,323 | $(192,507) | $1,048 | $(970,960) | $551,988 | $— | $551,988 |
| Net loss | — | — | — | — | (69,662) | (69,662) | — | (69,662) |
| Other comprehensive income for the period | — | — | — | 193 | — | 193 | — | 193 |
| Vesting of RSUs | 1,885 | (1,885) | — | — | — | — | — | — |
| Share-based compensation expense | — | 2,925 | — | — | — | 2,925 | — | 2,925 |
| March 31, 2026 | 418,969 | 1,298,363 | (192,507) | 1,241 | (1,040,622) | 485,444 | — | 485,444 |
| Net loss | — | — | — | — | (6,804) | (6,804) | — | (6,804) |
| Other comprehensive income for the period | — | — | — | 828 | — | 828 | — | 828 |
| Vesting of RSUs | 3,121 | (3,121) | — | — | — | — | — | — |
| Share issuance as part of legal settlement | 1,215 | (66) | — | — | — | 1,149 | — | 1,149 |
| Share-based compensation expense | — | 873 | — | — | — | 873 | — | 873 |
| June 30, 2026 | 423,305 | 1,296,049 | (192,507) | 2,069 | (1,047,426) | 481,490 | — | 481,490 |
| Net loss | — | — | — | — | (38,655) | (38,655) | — | (38,655) |
| Other comprehensive income for the period | — | — | — | 548 | — | 548 | — | 548 |
| Exercise of options and vesting of RSUs | 728 | (728) | — | — | — | — | — | — |
| Repurchase of treasury shares | — | — | (11,074) | — | — | (11,074) | — | (11,074) |
| Share-based compensation expense | — | 611 | — | — | — | 611 | — | 611 |
| September 30, 2026 | $424,033 | $1,295,932 | $(203,581) | $2,617 | $(1,086,081) | $432,920 | $— | $432,920 |
See Notes to Condensed Consolidated Financial Statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.